THE Medicines Control Authority of Zimbabwe (MCAZ), has approved the use of Johnson & Johnson vaccine in Zimbabwe in the management and prevention of COVID-19 infections.
By Michael Gwarisa
In an interview with HealthTimes, MCAZ Projects and Public Relations Officer, Mr Shingai Gwatidzo confirmed the development.
MCAZ reviewed the technical documentation and clinical studies conducted and issued Emergency Use Authorisation for Ministry of Health and Child Care to consider adding to the vaccines for use in Zimbabwe,” said Mr Gwatidzo.
He added that the EUA is subject to a number of considerations which include ensuring there is adequate cold storage capacity to store the vaccines and also ensuring there is robust side effect monitoring in place to monitor for potential side effects.
“MOHCC will then decide whether to deploy the vaccines in Zimbabwe or not, our responsibility is to ensure that we conduct the risk-benefit analysis.”